Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000199026 | SCV000303036 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000254531 | SCV000317546 | benign | Cardiovascular phenotype | 2015-06-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV000293317 | SCV000432936 | benign | Isolated Nonsyndromic Congenital Heart Disease | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Invitae | RCV001516693 | SCV001725008 | benign | Alagille syndrome due to a JAG1 point mutation | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001730575 | SCV001980833 | benign | Deafness, congenital heart defects, and posterior embryotoxon | 2021-08-19 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001516693 | SCV001980834 | benign | Alagille syndrome due to a JAG1 point mutation | 2021-08-19 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001730574 | SCV001980836 | benign | Tetralogy of Fallot | 2021-08-19 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000199026 | SCV003928846 | benign | not specified | 2023-04-04 | criteria provided, single submitter | clinical testing | |
Department of Ophthalmology and Visual Sciences Kyoto University | RCV000132569 | SCV000172511 | probable-non-pathogenic | not provided | no assertion criteria provided | not provided | Converted during submission to Likely benign. | |
Diagnostic Laboratory, |
RCV000199026 | SCV001741543 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000199026 | SCV001924655 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000199026 | SCV001926474 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000132569 | SCV001955124 | likely benign | not provided | no assertion criteria provided | clinical testing |